Remember Me
Or use your Academic/Social account:


Or use your Academic/Social account:


You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.


Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message


Verify Password:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Uauy, R (2007)
Publisher: Cambridge University Press (CUP)
Languages: English
Types: Article
The interaction between nutrition and infection is a key determinant of human health. Traditionally the interaction has centered on the role of nutrients in defining host defenses and the impact of infection in defining nutritional needs and status. Over the past decades the interaction has expanded its scope to encompass the role of specific nutrients in defining acquired immune function, in the modulation of inflammatory processes and on the virulence of the infectious agent itself. More recently the role of micronutrients and fatty acids on the response of cells and tissues to hypoxic and toxic damage has been recognized suggesting a fourth dimension to the interaction. The list of nutrients affecting infection, immunity, inflammation and cell injury has expanded from traditional protein-energy supply to several vitamins, multiple minerals and more recently specific lipid components of the diet. The promise of nutrition in the defense against infection, inflammation and tissue injury has spawned a thriving pharma-nutritional supplement industry and the development of novel foods that require appropriate evaluation of efficacy, safety and effectiveness relative to costs. Academics need to aware of the ethics and the pitfalls in the interaction with industry; conversely industry has to define its role in the process of bringing new knowledge to useful products. The process needs to be interactive, transparent and clearly place public interest above all other considerations.
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • 1. Scrimshaw NS, Taylor CE & Gordon JE (1968) Interactions of nutrition and infection. Monogr Ser World Health Organ 57, 3 - 329.
    • 2. Mata LJ, Kromal RA, Urrutia JJ & Garcia B (1977) Effect of infection on food intake and the nutritional state: perspectives as viewed from the village. Am J Clin Nutr 30, 1215 - 1227.
    • 3. Chandra RK (1984) Parasitic infection, nutrition, and immune response. Fed Proc 43, 251 - 255.
    • 4. Sirisinha S & Suskind R (1974) Host defenses in protein-calorie malnutrition. J Med Assoc Thai 57, 197 - 206.
    • 5. Chandra RK (1996) Nutrition, immunity and infection: from basic knowledge of dietary manipulation of immune responses to practical application of ameliorating suffering and improving survival. Proc Natl Acad Sci USA 93, 14304 - 14307.
    • 6. Bistrian BR, Blackburn GL, Vitale J, Cochran D & Naylor J (1976) Prevalence of malnutrition in general medical patients. Jama 235, 1567 - 1570.
    • 7. Beisel WR (1977) Magnitude of the host nutritional responses to infection. Am J Clin Nutr 30, 1236 - 1247.
    • 8. Gershwin ME, Keen CL, Mareschi JP & Fletcher MP (1991) Trace metal nutrition and the immune response. Compr Ther 17, 27 - 34.
    • 9. Keusch GT (1998) Nutrition and immunity: from A to Z. Nutr Rev 56, S3 - S4.
    • 10. Mascioli E, Leader L, Flores E, Trimbo S, Bistrian B & Blackburn G (1988) Enhanced survival to endotoxin in guinea pigs fed IV fish oil emulsion. Lipids 23, 623 - 625.
    • 11. Yaqoob P & Calder PC (1993) The effects of fatty acids on lymphocyte functions. Int J Biochem 25, 1705 - 1714.
    • 12. Meydani SN, Meydani M, Blumberg JB, et al. (1997) Vitamin E supplementation and in vivo immune response in healthy elderly subjects. A randomized controlled trial. JAMA 277, 1380 - 1386.
    • 13. Miller ER 3rd, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ & Guallar E (2005) Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med 142, 37 - 46.
    • 14. Mukherjee PK, Marcheselli VL, Serhan CN & Bazan NG (2004) Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. Proc Natl Acad Sci USA 101, 8491 - 8496.
    • 15. Schwab JM, Chiang N, Arita M & Serhan CN (2007) Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature 447, 869 - 874.
    • 16. Leathwood P, MacLean W & Uauy R (1999) The role of industry in bringing foods for particular nutritional uses (PARNUTS) to the market. Eur J Clin Nutr 53, Suppl 3, S9 - 13.
    • 17. Roberfroid MB (2000) Concepts and strategy of functional food science: the European perspective. Am J Clin Nutr 71, 1660S - 1664S, discussion 1674S-1665S.
    • 18. Dangour AD, Albala C, Aedo C, Elbourne D, Grundy E, Walker D & Uauy R (2007) A factorial-design cluster randomised controlled trial investigating the cost-effectiveness of a nutrition supplement and an exercise programme on pneumonia incidence, walking capacity and body mass index in older people living in Santiago, Chile: the CENEX study protocol [ISRCTN48153354]. Nutr J 6, 5 July 2007.
    • 19. Dangour AD, Clemens F, Elbourne D, et al. (2006) A randomised controlled trial investigating the effect of n-3 long-chain polyunsaturated fatty acid supplementation on cognitive and retinal function in cognitively healthy older people: the Older People And n-3 Long-chain polyunsaturated fatty acids (OPAL) study protocol [ISRCTN72331636]. Nutr J 5, (31 August 2006).
    • 20. Culliton BJ (1982) The academic-industrial complex. Science 216, 960 - 962.
    • 21. Jorgensen AW, Hilden J & Gotzsche PC (2006) Cochrane reviews compared with industry supported meta-analyses and other metaanalyses of the same drugs: systematic review. Bmj 333, 782.
    • 22. Smith R (2006) Conflicts of interest: how money clouds objectivity. J R Soc Med 99, 292 - 297.
    • 23. Blumenthal D, Campbell EG, Causino N & Louis KS (1996) Participation of life-science faculty in research relationships with industry. N Engl J Med 335, 1734 - 1739.
    • 24. Blumenthal D (2003) Academic-industrial relationships in the life sciences. N Engl J Med 349, 2452 - 2459.
    • 25. Margetts B (2006) Stopping the rot in nutrition science. Public Health Nutr 9, 169 - 173.
    • 26. McCrary SV, Anderson CB, Jakovljevic J, Khan T, McCullough LB, Wray NP & Brody BA (2000) A national survey of policies on disclosure of conflicts of interest in biomedical research. N Engl J Med 343, 1621 - 1626.
    • 27. Stossel TP (2005) Regulating academic-industrial research relationships - solving problems or stifling progress? N Engl J Med 353, 1060 - 1065.
    • 28. Federation of American Societies for Experimental Biology (FASEB) 2006 Shared responsibility, individual integrity: scientists addressing conflict of interest in biomedical research http://opa.faseb.org/pdf/FASEB_COI_paper_7x06.pdf accessed june 30, 2007.
  • No related research data.
  • No similar publications.

Share - Bookmark

Funded by projects

  • WT

Cite this article